Workflow
圆信永丰兴源A
icon
Search documents
机构风向标 | 天益医疗(301097)2025年三季度已披露前十大机构持股比例合计下跌1.10个百分点
Xin Lang Cai Jing· 2025-10-27 01:13
Core Viewpoint - Tianyi Medical (301097.SZ) reported a decline in institutional ownership in its Q3 2025 financial results, with a total of 4 institutional investors holding 1.4158 million shares, representing 2.40% of the total share capital, down by 1.10 percentage points from the previous quarter [1] Institutional Investors - A total of 4 institutional investors disclosed their holdings in Tianyi Medical, with a combined shareholding of 1.4158 million shares [1] - The institutional investors include: - China Merchants Bank Co., Ltd. - Penghua Hongjia Flexible Allocation Mixed Securities Investment Fund - Shanghai Xishirun Investment Management Co., Ltd. - Xishirun Beiyue No. 3 Private Securities Investment Fund - Jiangsu Zhaoxin Private Fund Management Co., Ltd. - Zhaoxin Collective No. 1 Private Securities Investment Fund - Industrial and Commercial Bank of China Co., Ltd. - CITIC Prudential Multi-Strategy Flexible Allocation Mixed Securities Investment Fund (LOF) [1] - The total institutional ownership percentage decreased to 2.40% compared to the previous quarter [1] Public Funds - One new public fund disclosed its holdings this quarter, namely CITIC Prudential Multi-Strategy Mixed (LOF) A [1] - A total of 49 public funds were not disclosed in this quarter compared to the previous quarter, including: - Yuanxin Yongfeng Ju You A - Yuanxin Yongfeng Medical Health A - Nuoan Multi-Strategy Mixed A - Yuanxin Yongfeng Xingyuan A - Penghua Double Bonds Poly Bond B [1]
机构风向标 | 圣诺生物(688117)2025年二季度已披露前十大机构持股比例合计下跌4.62个百分点
Xin Lang Cai Jing· 2025-08-15 01:08
Core Viewpoint - Saintno Bio (688117.SH) reported a decline in institutional ownership in its half-year report for 2025, with a total of 70.23 million shares held by eight institutional investors, representing 44.62% of the total share capital, down 4.62 percentage points from the previous quarter [1] Institutional Ownership - As of August 14, 2025, eight institutional investors disclosed their holdings in Saintno Bio, totaling 70.23 million shares, which is 44.62% of the company's total equity [1] - The institutional investors include Sichuan Sino Investment Co., Ltd., Sichuan Development Securities Investment Fund Management Co., Ltd., Lepu Medical Technology (Beijing) Co., Ltd., and several mutual funds [1] - Compared to the previous quarter, the total institutional ownership percentage decreased by 4.62 percentage points [1] Public Fund Disclosures - Four new public funds disclosed their holdings this period, including Huashang Intelligent Life Flexible Allocation Mixed A, Huashang Emerging Vitality Mixed, Huashang Core Growth One-Year Holding Mixed A, and Huashang Excellent Growth One-Year Holding Mixed A [1] - Seven public funds that were previously disclosed did not report this quarter, including Yuanxin Yongfeng Ju You A, China Merchants Medical Health Industry Stock, and several others [1]